New hope for lung cancer patients with devastating brain spread
Disease control
Not yet recruiting
This early-stage study is testing whether adding a new drug called Zorifertinib to a standard treatment (Osimertinib) is safe and effective. It is for adults with a specific type of advanced lung cancer where the disease has spread to the protective membranes around the brain and…
Phase: PHASE1 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC